Ich stimme der Verwendung von Cookies zu. Auch wenn ich diese Website weiter nutze, gilt dies als Zustimmung.

Bitte lesen und akzeptieren Sie die Datenschutzinformation und Cookie-Informationen, damit Sie unser Angebot weiter nutzen können. Natürlich können Sie diese Einwilligung jederzeit widerrufen.






21st Austria weekly - Agrana (11/05/2021)

16.05.2021

Agrana: In the 2020|21 financial year, fruit-, starch- and sugar company Agrana Beteiligungs-AG achieved a slight increase in Group revenue to Euro 2,547.0 mn. Operating profit (EBIT), at Euro 78.7 mn, rose 17.6% from the prior year. In the year under review, the Covid-19 pandemic was the defining factor for all business segments. In the Fruit segment, earnings of the fruit preparations business were up from a year ago despite one-off effects. In the fruit juice concentrate business, by contrast, poor apple harvests coincided with pandemic-related weak demand, especially in the food service and tourism sectors, which led to a significantly reduced earnings performance. In the Starch segment, reduced starch volumes sold to the graphic paper industry (the print sector) were offset by increased sales to corrugated cardboard manufacturers (packaging). Starch margins on balance were lower for demand reasons and the segment's operating performance was thus down from the prior year. In the Sugar segment, higher sugar prices and volumes contributed to a significant year-on-year improvement in the - albeit still negative - bottom line. "Despite the extraordinary conditions created by the Covid-19 pandemic, we delivered solid results in the last financial year. Overall, what is once again clear is that our stable business performance is due in large part to the diversification of our business segments," says Agrana Chief Executive Officer Johann Marihart.
Agrana: weekly performance: 1.47%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (11/05/2021)


Partners









latest 21st Austria

21st Austria weekly - Agrana (11/05/2021)


16.05.2021, 1592 Zeichen



Agrana: In the 2020|21 financial year, fruit-, starch- and sugar company Agrana Beteiligungs-AG achieved a slight increase in Group revenue to Euro 2,547.0 mn. Operating profit (EBIT), at Euro 78.7 mn, rose 17.6% from the prior year. In the year under review, the Covid-19 pandemic was the defining factor for all business segments. In the Fruit segment, earnings of the fruit preparations business were up from a year ago despite one-off effects. In the fruit juice concentrate business, by contrast, poor apple harvests coincided with pandemic-related weak demand, especially in the food service and tourism sectors, which led to a significantly reduced earnings performance. In the Starch segment, reduced starch volumes sold to the graphic paper industry (the print sector) were offset by increased sales to corrugated cardboard manufacturers (packaging). Starch margins on balance were lower for demand reasons and the segment's operating performance was thus down from the prior year. In the Sugar segment, higher sugar prices and volumes contributed to a significant year-on-year improvement in the - albeit still negative - bottom line. "Despite the extraordinary conditions created by the Covid-19 pandemic, we delivered solid results in the last financial year. Overall, what is once again clear is that our stable business performance is due in large part to the diversification of our business segments," says Agrana Chief Executive Officer Johann Marihart.
Agrana: weekly performance: 1.47%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (11/05/2021)



BSN Podcasts
Christian Drastil: Wiener Börse Plausch

kapitalmarkt-stimme.at daily voice 13/365: Die KESt-Behaltefrist, warum sie das heisseste Thema ist und eine kurze Frist her muss




 

Bildnachweis

Aktien auf dem Radar:Kapsch TrafficCom, Austriacard Holdings AG, EuroTeleSites AG, Flughafen Wien, Warimpex, Mayr-Melnhof, Erste Group, ATX, ATX Prime, ATX TR, OMV, Wienerberger, Cleen Energy, DO&CO, Pierer Mobility, Stadlauer Malzfabrik AG, Semperit, Strabag, Josef Manner & Comp. AG, Agrana, Amag, Rosenbauer, Oberbank AG Stamm, RHI Magnesita, EVN, Palfinger, Österreichische Post, Telekom Austria, Uniqa, VIG.


Random Partner

Croma
Croma Pharma® ist ein österreichisches Familienunternehmen mit Sitz in Leobendorf. Das Unternehmen ist auf die industrielle Fertigung von Hyaluronsäure-Spritzen spezialisiert und zählt in diesem Bereich europaweit zu den führenden Experten. Das Unternehmen setzt mit eigenen Marken auf die Wachstumssparte der minimalinvasiven ästhetischen Medizin.

>> Besuchen Sie 68 weitere Partner auf boerse-social.com/partner


Useletter

Die Useletter "Morning Xpresso" und "Evening Xtrakt" heben sich deutlich von den gängigen Newslettern ab. Beispiele ansehen bzw. kostenfrei anmelden. Wichtige Börse-Infos garantiert.

Newsletter abonnieren

Runplugged

Infos über neue Financial Literacy Audio Files für die Runplugged App
(kostenfrei downloaden über http://runplugged.com/spreadit)

per Newsletter erhalten